BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38614235)

  • 1. Comparing the outcomes of rheumatic heart disease in pregnancy complicated with and without atrial fibrillation: A propensity score matched analysis.
    Keepanasseril A; Pande SN; Suriya Y; Baghel J; Mondal N; Pillai AA; Satheesh S; Siu SC
    Am Heart J; 2024 Jul; 273():140-147. PubMed ID: 38614235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.
    Karthikeyan G; Connolly SJ; Ntsekhe M; Benz A; Rangarajan S; Lewis G; Yun Y; Sharma SK; Maklady F; Elghamrawy AE; Kazmi K; Cabral TTJ; Dayi H; Changsheng M; Gitura BM; Avezum A; Zuhlke L; Lwabi P; Haileamlak A; Ogah O; Chillo P; Paniagua M; ElSayed A; Dans A; Gondwe-Chunda L; Molefe-Baikai OJ; Gonzalez-Hermosillo JA; Hakim J; Damasceno A; Kamanzi ER; Musuku J; Davletov K; Connolly K; Mayosi BM; Yusuf S;
    Am Heart J; 2020 Jul; 225():69-77. PubMed ID: 32474206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial Fibrillation and Atrial Flutter in Pregnant Women-A Population-Based Study.
    Lee MS; Chen W; Zhang Z; Duan L; Ng A; Spencer HT; Kwan DM; Shen AY
    J Am Heart Assoc; 2016 Apr; 5(4):e003182. PubMed ID: 27076563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal and fetal outcomes in pregnant females with rheumatic heart disease.
    Khanna R; Chandra D; Yadav S; Sahu A; Singh N; Kumar S; Garg N; Tewari S; Kapoor A; Pradhan M; Goel PK
    Indian Heart J; 2021; 73(2):185-189. PubMed ID: 33865516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Spectrum, Severity and Outcomes of Rheumatic Mitral Valve Disease in Pregnant Women in Australia and New Zealand.
    Rémond MGW; Li Z; Vaughan G; Frawley J; Peek MJ; Carapetis JR; Remenyi B; Parsonage W; McLintock C; Sullivan EA
    Heart Lung Circ; 2022 Apr; 31(4):480-490. PubMed ID: 34840063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-Analysis of the Incidence, Prevalence, and Correlates of Atrial Fibrillation in Rheumatic Heart Disease.
    Noubiap JJ; Nyaga UF; Ndoadoumgue AL; Nkeck JR; Ngouo A; Bigna JJ
    Glob Heart; 2020 May; 15(1):38. PubMed ID: 32923332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, clinical characteristics and outcomes of valvular atrial fibrillation in a cohort of African patients with acute heart failure: insights from the THESUS-HF registry.
    Sani MU; Davison BA; Cotter G; Mayosi BM; Edwards C; Ogah OS; Damasceno A; Ojji DB; Dzudie A; Mondo C; Kouam CK; Suliman A; Yonga G; Ba SA; Maru F; Alemayehu B; Sliwa K
    Cardiovasc J Afr; 2018; 29(3):139-145. PubMed ID: 30067272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry.
    Negi PC; Sondhi S; Rana V; Rathoure S; Kumar R; Kolte N; Kumar R; Rao S; Diman A; Mahajan K; Dev M; Kandoria A; Ganju N; Bhardwaj R; Merwaha R; Sharma R; Asotra S
    Indian Heart J; 2018 Dec; 70 Suppl 3(Suppl 3):S68-S73. PubMed ID: 30595324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease.
    Baghel J; Keepanasseril A; Pillai AA; Mondal N; Jeganathan Y; Kundra P
    Heart; 2020 Sep; 106(18):1400-1406. PubMed ID: 32601124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Burden of Cardiac Disease in Pregnancy at a National Referral Hospital in Western Kenya.
    Lumsden R; Barasa F; Park LP; Ochieng CB; Alera JM; Millar HC; Bloomfield GS; Christoffersen-Deb A
    Glob Heart; 2020 Feb; 15(1):10. PubMed ID: 32489783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy related complications in women with hypertrophic cardiomyopathy: a nationwide population-based cohort study.
    Choi WY; Park KT; Kim HM; Cho JH; Nam G; Hong J; Kang D; Lee J
    BMC Cardiovasc Disord; 2024 May; 24(1):268. PubMed ID: 38773383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renin-angiotensin system inhibitors on long-term clinical outcomes of patients with rheumatic heart disease.
    Liu C; Lai Y; Wu D; Fu R; Li Y; Li H; Guan T; Shen Y
    ESC Heart Fail; 2021 Dec; 8(6):5338-5351. PubMed ID: 34545695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure in pregnant women with cardiac disease: data from the ROPAC.
    Ruys TP; Roos-Hesselink JW; Hall R; Subirana-Domènech MT; Grando-Ting J; Estensen M; Crepaz R; Fesslova V; Gurvitz M; De Backer J; Johnson MR; Pieper PG
    Heart; 2014 Feb; 100(3):231-8. PubMed ID: 24293523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rheumatic heart disease in pregnancy: cardiac and obstetric outcomes.
    Sartain JB; Anderson NL; Barry JJ; Boyd PT; Howat PW
    Intern Med J; 2012 Sep; 42(9):978-84. PubMed ID: 22288941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and fetal outcome in women with rheumatic heart disease: a 3-year observational study.
    Rezk M; Gamal A
    Arch Gynecol Obstet; 2016 Aug; 294(2):273-8. PubMed ID: 26700422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stroke risk prediction in patients with atrial fibrillation with and without rheumatic heart disease.
    Benz AP; Healey JS; Chin A; Commerford P; Marsden T; Karthikeyan G; McIntyre WF; Wong JA; Damasceno A; Hohnloser SH; Oldgren J; Wallentin L; Ezekowitz MD; Eikelboom JW; Yusuf S; Connolly SJ
    Cardiovasc Res; 2022 Jan; 118(1):295-304. PubMed ID: 33386845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maternal and Fetal Outcomes of Admission for Delivery in Women With Congenital Heart Disease.
    Hayward RM; Foster E; Tseng ZH
    JAMA Cardiol; 2017 Jun; 2(6):664-671. PubMed ID: 28403428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry.
    Karthikeyan G; Devasenapathy N; Zühlke L; Engel ME; Rangarajan S; Teo KK; Mayosi BM; Yusuf S;
    Heart; 2019 Mar; 105(5):363-369. PubMed ID: 30209123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The personal and clinical impact of screen-detected maternal rheumatic heart disease in Uganda: a prospective follow up study.
    Voleti S; Okello E; Murali M; Sarnacki R; Majwala A; Ssembatya R; Bakka O; Namisanvu H; Njeri A; Matovu A; DeStigter K; Sable C; Beaton A
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):611. PubMed ID: 33036571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and predictors of de novo late-onset persistent atrial fibrillation in postoperative rheumatic heart disease patients (LOAF-RHD study).
    Sharma G; Ghati N; Doshi S; Sharma S; Sharique M; Agarwal A; Devagourou V; Hote MP; Choudhary SK
    J Interv Card Electrophysiol; 2022 Sep; 64(3):621-628. PubMed ID: 34748162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.